Practical considerations in the use of regorafenib in metastatic colorectal cancer

Over the past 20 years, management of patients with metastatic colorectal cancer (mCRC) has improved considerably, leading to increased overall survival and more patients eligible for third- or later-line therapy. Currently, two oral therapies are recommended in the third-line treatment of mCRC, reg...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Ther Adv Med Oncol
Prif Awduron: Loupakis, Fotios, Antonuzzo, Lorenzo, Bachet, Jean-Baptiste, Kuan, Feng-Che, Macarulla, Teresa, Pietrantonio, Filippo, Xu, Rui-Hua, Taniguchi, Hiroya, Winder, Thomas, Yuki, Satoshi, Zeng, Shan, Bekaii-Saab, Tanios
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: SAGE Publications 2020
Pynciau:
Review
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7607787/
https://ncbi.nlm.nih.gov/pubmed/33193826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920956862
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg